Evidence map›Paper›PMID 27631872›Full record

ArticleWiener medizinische Wochenschrift (1946)2017

Botulinum toxin A and/or soft tissue fillers for facial rehabilitation.

Uwe Wollina, Alberto Goldman

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Wiener medizinische Wochenschrift (1946), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Botulinum toxin A treatment in facial palsy synkinesis: a systematic review and meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2023
    Pooled it
  2. Article
  3. Article
  4. The Treatment of Facial Asymmetry with Botulinum Toxin: Current Concepts, Guidelines, and Future Trends.Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Uwe WollinaDepartment of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Friedrichstrasse 41, 01067, Dresden, Germany. wollina-uw@khdf.de.
Alberto GoldmanClinica Goldman, Porto Alegre/RS, Brazil.
Hospital de Clínicas de Porto Alegre · BRKrankenhaus Dresden-Friedrichstadt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Botulinum toxin A and soft tissue fillers are cornerstones of facial rejuvenation procedures. They can also be of benefit in facial rehabilitation. We report on three female patients who were treated with botulinum toxin A and/or hyaluronic acid-based fillers, one after orthognathic surgery, two after Bell's palsy, to correct facial asymmetries and loss of volume to restore facial attractiveness and improve their self-esteem and quality of life. These minimally invasive procedures are safe and effective. However, they need to be repeated for the long-term rehabilitation.

Indexed as

Cosmetic TechniquesOrthognathic SurgeryAdolescentAdultBell PalsyBotulinum Toxins, Type ACombined Modality TherapyFacial AsymmetryFemaleFollow-Up StudiesHumansHyaluronic AcidPatient SatisfactionPostoperative ComplicationsRejuvenationBotulinum Toxins, Type AHyaluronic AcidBell’s palsyBotulinum toxin AFacial rehabilitationOrthognathic surgerySoft tissue fillers

Identifiers

PMID27631872
OpenAlexW2522340981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.